Atualização sobre a esquistossomose mansônica no Brasil: uma revisão integrativa
Authors:
- Isaias Sena Moraes de SouzaISIsaias Sena Moraes de Souza
- Laura Maria de Araújo PereiraLPLaura Maria de Araújo Pereira
- Senyra Maria das NevesSNSenyra Maria das Neves
- Dominique de Souza FariasDFDominique de Souza Farias
- Jemima Silva InocêncioJIJemima Silva Inocêncio
- Luiz Marinho de Lucena NetoLNLuiz Marinho de Lucena Neto
- Jhonatta Alexandre Brito DiasJDJhonatta Alexandre Brito Dias
- Antonio Carlos Vital JúniorAJAntonio Carlos Vital Júnior
- Daniel José GonçalvesDGDaniel José Gonçalves
- Helimarcos Nunes PereiraHPHelimarcos Nunes Pereira
- José Guedes da Silva JúniorJJJosé Guedes da Silva Júnior
Open Access
- 21 April 2023
- journal article
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (5)
Abstract
The present work performs an integrative review of the literature on schistosomiasis in Brazil, a parasitic and waterborne disease caused by flatworms of the genus Schistosoma (S. mansoni; S. japonicum; S. haematobium), and which still manifests itself as a problem significant public health problem in this country. It aims to highlight clinical data, as well as epidemiological data, presenting the most affected regions, individuals most vulnerable to infection and factors associated with its occurrence. In addition, it aims to update the current scenario with regard to the development of a vaccine against the parasites that cause schistosomiasis. The study carried out analyzes in the PubMed and Latin American and Caribbean Literature in Health Sciences (LILACS), ScienceDirect databases, as well as using data from the World Health Organization (WHO), the Centers For Disease Control and Prevention (CDC) and the Ministry of Health of Brazil (MS). It is concluded that schistosomiasis remains a disease of high national relevance, since it still manifests itself as a public health problem, responsible for intensifying situations of social inequality and having a direct connection with poverty, as a cause, but also as a consequence of same. Currently, several vaccines are in the clinical trial phase, but none is commercially available, and investment in research is of great importance.Keywords
This publication has 13 references indexed in Scilit:
- Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programsInternational Journal for Parasitology: Drugs and Drug Resistance, 2020
- Analysis and spatial distribution of schistosomiasis mansoni in a historically endemic area of northeastern BrazilTropical Medicine & International Health, 2020
- Schistosomiasis vaccine development: update on human clinical trialsJournal of Biomedical Science, 2020
- O desenvolvimento de vacinas contra as doenças tropicais negligenciadasCadernos de Saude Publica, 2020
- New epidemiological profile of schistosomiasis from an area of low prevalence in BrazilRevista da Sociedade Brasileira de Medicina Tropical, 2020
- Schistosomiasis: an epidemiological update on Brazil's southernmost low endemic area in EsteioRevista da Sociedade Brasileira de Medicina Tropical, 2020
- The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoniMemórias do Instituto Oswaldo Cruz, 2019
- Prevalence of schistosomiasis mansoni in indigenous Maxakali villages, Minas Gerais, BrazilRevista do Instituto de Medicina Tropical de São Paulo, 2018
- Socioenvironmental factors associated with Schistosoma mansoni infection and intermediate hosts in an urban area of northeastern BrazilPLOS ONE, 2018
- Epidemiology and Eradication of Schistosomiasis Japonica in JapanJournal of Travel Medicine, 1998